Presentation TCT 2016 The AUGUSTUS Trial: Apixaban in Patients With Atrial Fibrillation and ACS/PCI: Design, Rationale, and Status Presenter: Freek W.A. Verheugt, Pascal Vranckx, Roxana Mehran November 01, 2016
News Daily News More NOAC Comparisons See Higher Bleeding Risk With Rivaroxaban: Is the ‘Writing on the Wall’? Shelley Wood October 07, 2016
News Daily News Low-Dose NOACs Top Warfarin in Asian Patients in Everyday Practice, Retrospective Study Suggests Todd Neale September 26, 2016
News Daily News Las Dosis Bajas de Superan a la Warfarina en Pacientes Asiáticos en la Práctica Rutinaria, según un Estudio Retrospectivo Todd Neale September 26, 2016
News Daily News Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns Shelley Wood September 13, 2016
News Daily News Riesgo de ACV con TAVR: Una Revisión en Profundidad de los Datos del PARTNER y CoreValve Revela Oportunidades e Incógnitas Shelley Wood September 13, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for August 2016 Caitlin E. Cox September 01, 2016
News Conference News ESC 2016 Reversal Agent for Factor Xa Inhibitors Rapidly Reduces Anticoagulant Effects: ANNEXA-4 Todd Neale August 31, 2016
News Conference News ESC 2016 Edoxaban Shows Safety, Efficacy for A-fib Patients Undergoing Cardioversion: ENSURE-AF Todd Neale August 30, 2016
News Conference News ESC 2016 NOACs as Effective as Warfarin for Reducing Stroke, but Apixaban and Dabigatran May Carry Lower Bleeding Risk: Registry Michael O'Riordan August 28, 2016
News Daily News FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors Michael O'Riordan August 18, 2016
News Daily News Data Gap: Best Strategy Unknown for A-Fib Patients on Newer Anticoagulants Who Need PCI L.A. McKeown August 17, 2016
News Daily News Ausencia de Datos: No Sabemos Cuál es la Mejor Estrategia para el Manejo de Pacientes con FA a Tratamiento con los Últimos Anticoagulantes y que Necesitan una PCI L.A. McKeown August 17, 2016
News Daily News Antithrombotic Cocktail Fails to Provide Benefit, Increases Bleeding in A-Fib Patients Undergoing TAVR Yael L. Maxwell August 16, 2016
News Daily News ARISTOTLE Analysis: Don’t Shy Away From Standard Apixaban Dose in Certain High-Risk Patients Todd Neale July 29, 2016
News Daily News Thrombus Relatively Common After LAA Occlusion With Amplatzer Amulet, Small Study Suggests Todd Neale July 28, 2016
News Daily News Study Provides More Evidence That Having A-fib Ups Risk of Developing Dementia L.A. McKeown July 19, 2016
News Daily News Según una Revisión las Evidencias que Avalan la Exclusión Percutánea o Quirúrgica del AAI para la Prevención de ACV son Limitadas Todd Neale July 14, 2016